These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 34187692)

  • 21. Relationship between neuromelanin and dopamine terminals within the Parkinson's nigrostriatal system.
    Martín-Bastida A; Lao-Kaim NP; Roussakis AA; Searle GE; Xing Y; Gunn RN; Schwarz ST; Barker RA; Auer DP; Piccini P
    Brain; 2019 Jul; 142(7):2023-2036. PubMed ID: 31056699
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Free-water imaging in Parkinson's disease and atypical parkinsonism.
    Planetta PJ; Ofori E; Pasternak O; Burciu RG; Shukla P; DeSimone JC; Okun MS; McFarland NR; Vaillancourt DE
    Brain; 2016 Feb; 139(Pt 2):495-508. PubMed ID: 26705348
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Differential Alterations in Metabolism and Proteolysis-Related Proteins in Human Parkinson's Disease Substantia Nigra.
    Grünblatt E; Ruder J; Monoranu CM; Riederer P; Youdim MB; Mandel SA
    Neurotox Res; 2018 Apr; 33(3):560-568. PubMed ID: 29218503
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Spatiotemporal changes in substantia nigra neuromelanin content in Parkinson's disease.
    Biondetti E; Gaurav R; Yahia-Cherif L; Mangone G; Pyatigorskaya N; Valabrègue R; Ewenczyk C; Hutchison M; François C; Arnulf I; Corvol JC; Vidailhet M; Lehéricy S
    Brain; 2020 Sep; 143(9):2757-2770. PubMed ID: 32856056
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Centenary of Tretiakoff's thesis on the morphology of Parkinson's disease, evolved on the grounds of encephalitis lethargica pathology.
    Holdorff B
    J Hist Neurosci; 2019; 28(4):387-398. PubMed ID: 31226240
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The spatiotemporal changes in dopamine, neuromelanin and iron characterizing Parkinson's disease.
    Biondetti E; Santin MD; Valabrègue R; Mangone G; Gaurav R; Pyatigorskaya N; Hutchison M; Yahia-Cherif L; Villain N; Habert MO; Arnulf I; Leu-Semenescu S; Dodet P; Vila M; Corvol JC; Vidailhet M; Lehéricy S
    Brain; 2021 Nov; 144(10):3114-3125. PubMed ID: 33978742
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The history of drugs for the treatment of Parkinson's disease.
    Kapp W
    J Neural Transm Suppl; 1992; 38():1-6. PubMed ID: 1491242
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Dopamine reduction in the substantia nigra of Parkinson's disease patients confirmed by in vivo magnetic resonance spectroscopic imaging.
    Gröger A; Kolb R; Schäfer R; Klose U
    PLoS One; 2014; 9(1):e84081. PubMed ID: 24416192
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Four pioneers of L-dopa treatment: Arvid Carlsson, Oleh Hornykiewicz, George Cotzias, and Melvin Yahr.
    Lees AJ; Tolosa E; Olanow CW
    Mov Disord; 2015 Jan; 30(1):19-36. PubMed ID: 25488030
    [TBL] [Abstract][Full Text] [Related]  

  • 30. From hysteria to gait dementia: History of the concept of astasia-abasia.
    Walusinski O
    Rev Neurol (Paris); 2023 Jun; 179(6):523-532. PubMed ID: 37030986
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Asymmetry of substantia nigra neuronal loss in Parkinson's disease and its relevance to the mechanism of levodopa related motor fluctuations.
    Kempster PA; Gibb WR; Stern GM; Lees AJ
    J Neurol Neurosurg Psychiatry; 1989 Jan; 52(1):72-6. PubMed ID: 2709038
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Morphochemical changes in the substantia nigra cellular structures in Parkinson's disease].
    Salkov VN; Khudoerkov RM; Voronkov DN; Sobolev VB; Kutukova KA
    Arkh Patol; 2017; 79(5):3-9. PubMed ID: 29027522
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Neurochemical and morphological changes of microstructures of the compact part of the substantia nigra of human brain in aging and Parkinson's disease (literature review).].
    Salkov VN; Khudoerkov RM
    Adv Gerontol; 2018; 31(5):662-667. PubMed ID: 30638319
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Topographical alterations of the midbrain and the substantia nigra following unilateral posteroventral pallidotomy in patients with Parkinson's disease using routine and multishot diffusion-weighted magnetic resonance imaging.
    Adachi M; Kurimura M; Saito S; Hosoya T; Kayama T; Kato T
    Neuroradiology; 2002 Jul; 44(7):579-85. PubMed ID: 12136359
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Marcel Proust's lifelong tour of the Parisian Neurological Intelligentsia: from Brissaud and Dejerine to Sollier and Babinski.
    Bogousslavsky J
    Eur Neurol; 2007; 57(3):129-36. PubMed ID: 17213718
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Brain monoamine oxidase B and A in human parkinsonian dopamine deficiency disorders.
    Tong J; Rathitharan G; Meyer JH; Furukawa Y; Ang LC; Boileau I; Guttman M; Hornykiewicz O; Kish SJ
    Brain; 2017 Sep; 140(9):2460-2474. PubMed ID: 29050386
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hyperechogenicity of substantia nigra for differential diagnosis of Parkinson's disease: A meta-analysis.
    Shafieesabet A; Fereshtehnejad SM; Shafieesabet A; Delbari A; Baradaran HR; Postuma RB; Lökk J
    Parkinsonism Relat Disord; 2017 Sep; 42():1-11. PubMed ID: 28647434
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Longitudinal changes in free-water within the substantia nigra of Parkinson's disease.
    Ofori E; Pasternak O; Planetta PJ; Li H; Burciu RG; Snyder AF; Lai S; Okun MS; Vaillancourt DE
    Brain; 2015 Aug; 138(Pt 8):2322-31. PubMed ID: 25981960
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Correlation of striatal dopamine transporter imaging with post mortem substantia nigra cell counts.
    Kraemmer J; Kovacs GG; Perju-Dumbrava L; Pirker S; Traub-Weidinger T; Pirker W
    Mov Disord; 2014 Dec; 29(14):1767-73. PubMed ID: 25048738
    [TBL] [Abstract][Full Text] [Related]  

  • 40. James Parkinson and his essay on "shaking palsy", two hundred years later.
    Palacios-Sánchez L; Torres Nupan M; Botero-Meneses JS
    Arq Neuropsiquiatr; 2017 Sep; 75(9):671-672. PubMed ID: 28977149
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.